Results 81 to 90 of about 259,087 (197)

Progress and Challenges of Messenger RNA Vaccines in the Therapeutics of NSCLC. [PDF]

open access: yesCancers (Basel), 2023
Kiousi E   +8 more
europepmc   +1 more source

Current Trends in Messenger RNA Technology for Cancer Therapeutics. [PDF]

open access: yesBiomater Res
Afzal A   +4 more
europepmc   +1 more source

Identification of Messenger RNA Signatures in Age-Dependent Renal Impairment. [PDF]

open access: yesDiagnostics (Basel), 2023
Yanai K   +5 more
europepmc   +1 more source

The Lifetime of Bacterial Messenger RNA

open access: yes, 1963
Puromycin, an inhibitor of protein synthesis, appears to act as an inhibitor at additional sites during the induction of {beta}-galactosidase synthesis. No inhibition of the reactions proceeding during the first 20 seconds of induction was observed, but puromycin seems to prevent the accumulation of messenger RNA during the period between 20 seconds ...
Moses, V., Calvin, M.
openaire   +3 more sources

Home - About - Disclaimer - Privacy